Results: The 3D-pharmacophore model was developed containing five pharmacophoric features comprising H-bond acceptor (F1: Acc2), two hydrophobic center (F2: Hyd and F4: Hyd) and two aromatic center | Pi ring center (F3: Aro|PiR and F5: Aro|PiR) from 6 drug candidates.